A codon-optimised synthetic gene encoding hGWL-KinDom was cloned into the expression vector pTHREE-E, which adds a rhinovirus 3C-protease cleavable GST affinity-tag to the front of the encoded protein. E. coli strain Rosetta2(DE3) was transformed with pTHREE-E/hGWL-KinDom [Merck-Millipore, Watford, UK]. A 'starter culture' was prepared by inoculating 50 ml of Turbo-broth [Molecular Dimensions, Newmarket, UK] supplemented with 100 μg/ml ampicillin and 34 μg/ml chloramphenicol. This was then incubated at 37 °C, in an orbital shaking incubator set at 220 rpm, until the absorbance at a wavelength of 600nm (A600) reached 1.0. The culture was then stored overnight at 4 °C. The following day, 10 ml of the starter culture was used to inoculate 1 litre of Turbo-Broth in a 2 litre Erlenmeyer flask (supplemented as before with antibiotics). Again, the culture was incubated at 37 °C, in an orbital shaking incubator set at 220 rpm, until the A600 reached 2.0. The Erlenmeyer flask was then placed on ice and the temperature of the incubator reduced to 16 °C. When this temperature was attained, the flask was placed back into the incubator, and recombinant protein expression induced by the addition of IPTG (isopropyl β-D-1-thiogalactopyranoside) to a final concentration of 0.5 mM. The culture was then incubated for a further period of ~16 hours. Cells were then harvested by centrifugation (5000 x g, 10 minutes, 4 °C) and the resultant pellet stored at -20 °C until required.
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The supernatant arising from this step was applied to a batch / gravity column containing 10 ml of Amintra Glutathione Resin [Expedeon Ltd, Harston, UK] pre-equilibrated in Buffer A. The column containing the cell extract and resin was rotated / rolled at 4 °C for a period of 1-2 hours to facilitate protein binding, and then allowed to pack under gravity flow. The resin was then washed with the addition of 10 column volumes (CV) of Buffer A to remove any unbound material, then re-suspended in an equal volume of Buffer B: 50 mM HEPES.NaOH pH 7.5, 500 mM NaCl, 150 mM KCl, 10 mM MgCl 2 , 10 mM ATP, 0.5 mM TCEP, and rotated / rolled for a further period of 2 hours at 4 °C. The resin was once again allowed to pack under gravity flow, followed by an additional wash with a further 5 CV of Buffer A. Rhinovirus 3C-protease was then added to the resin slurry (200 µl of a 2 mg/ml stock solution) and the cleavage reaction allowed to proceed overnight, with rotation / rolling at 4 °C as before.
The following day, the resin was again allowed to pack under gravity flow, but this time collecting the flowthrough. Fractions containing hGWL-KinDom were identified by SDS-PAGE, pooled, and then concentrated using centrifugal ultra-filtration [10,000 MWCO Vivaspin 20, Sartorius Stedim UK Ltd, Epson, UK], before being applied to a HiLoad 26/60 Superdex 75 size exclusion chromatography column [GE Healthcare, Litte Chalfont, UK], pre-equilibrated in Buffer C: 20 mM HEPES.NaOH pH 7.5, 300 mM NaCl, 0.5 mM TCEP. Again, fractions containing hGWL-KinDom were identified by SDS-PAGE, pooled, and then concentrated to a final concentration of 12 mg/ml, and stored at -80 °C until required.
Crystallisation and data collection hGWL-KinDom was co-crystallised with staurosporine (STU), by firstly mixing purified protein at 12 mg/ml with STU (20 mM stock solution) in a 1:3 protein:ligand ratio, and then incubating on ice for a period of 3 hours, before setting up sitting drop vapour diffusion experiments at 4 °C; where 1 μl of complex was mixed with 1 µl of crystallisation buffer and equilibrated against a well volume of 50µl. Crystals were obtained in condition D12 of the PEG/Ion HT screen (0.2 M ammonium citrate, 20% w/v polyethylene glycol 3350; Hampton Research, California, USA). Crystals were swiped successively through buffers containing increasing concentrations of cryo-protectant, before being plunged into liquid nitrogen; 30% v/v glycerol was sufficient to prevent ice formation. Diffraction data to 3.1 Å resolution were collected at the Diamond Light Source [DLS, Didcot, UK] on beamline I03.
Phasing, model building and refinement
All diffraction data were collected at 100K. Data were integrated using the software package XDS (1), and then processed using the Pointless / Aimless / Ctruncate pipeline of the CCP4 software suite (2) (3) (4) (5) . Phases were obtained by molecular replacement using Phaser (6) with a polyalanine model based on PDB: 1H1W (PDK1; 
Thermal shift assay
For thermal denaturation, samples containing protein at 1.5 M and 5 x SYPRO Orange (diluted from a 5000 x stock supplied in DMSO; Sigma-Aldrich, Gillingham, UK) were prepared in sample buffer: 20 mM HEPES.NaOH pH 7.5, 300 mM NaCl, 0.5 mM TCEP. Denaturation curves were monitored in 96-well PCR plates using a Roche LightCycler 480 II, with 465 and 580 nm filters for excitation and emission wavelengths, respectively. The program was as follows: 1 min at 20°C, followed by a continuous increment of 0.03°C/s to a final temperature of 85°C. Temperature midpoints (Tm) for each folded to unfolded transition were determined by non-linear regression fitting of a modified Boltzmann model to normalized data in Prism 6.0 (version 6.0h, GraphPad Software, La Jolla, CA USA).
Where: a n and a d are the slopes, and b n and b d the y-intercepts, of the native and denatured baselines respectively. T m is the temperature midpoint of the transition from native to denatured states, and m represents a generic slope factor.
Kinase Assays
Non-radioactive kinase assays were set-up by combining hGWL-KinDom (305 M in 20 mM HEPES pH 7.5, 500 mM NaCl, and 0.5 mM TCEP) diluted to desired concentration or immunoprecipitated hGWL FL on beads with ultra-pure ATP [Promega, 25 M] and His-tagged substrate -endosulfine (ENSA, 2 M) in kinase assay buffer (50 mM Tris-HCl pH 7.5, 0.5 mM EGTA, 150 mM NaCl, 0.1% v/v NP-40 and 15 mM MgCl 2 ). The reaction was allowed to proceed for 30 min at 37 °C or another indicated time-point after which it was stopped with either SDS loading buffer (5X buffer, including 0.25 % w/v Bromophenol blue, 0.5 M DTT (dithiothreitol), 50% v/v Glycerol, 10% v/v SDS (sodium dodecyl sulphate), and 0.25M Tris-HCl pH 6.8) or Kinase-Glo Max reagent [Promega] . Recombinant His-tagged ENSA was purified using Ni-NTA agarose [QIAGEN] from BL21 E. coli following the manufacturer's recommended protocol.
Radioactive Kinase Assay
To detect ENSA phosphorylated at Ser67 (p-ENSA), the standard kinase reaction was spiked with 0.075 MBq -32 P ATP (PerkinElmer, Seer Green, UK) per 20 l reaction. After the reaction was stopped with 5 l 5X SDS loading buffer and boiled for 5 min at 95 °C the mixture was resolved via SDS-PAGE (4-15% Criterion pre-cast gels; Bio-Rad Laboratories, Hemel Hempstead, UK, or 13% SDS-polyacrylamide gels). Staining with coomassie-blue revealed an ~17 kDa band that was imaged by autoradiography. All kinase assays were repeated thrice per assay condition and each point on the concentration-dependent response curves represents the mean ± 1 S.D.
Kinase-Glo Max Assay
After stopping the above non-radioactive kinase assay with 1 volume of Kinase-Glo Max reagent the mixture was allowed to incubate for a further 15 min. To detect consumption of ATP, samples were transferred to white, flat-bottom 96-well plates [Thermo Fisher Scientific, Loughborough, UK] and luminescence was detected using a POLARstar Omega micro-plate reader [BMG Labtech GmbH, Ortenberg, Germany]. As this assay measures ATP, activity or ATP turnover was measured as the -ΔRLU. Non-linear regression using Prism 6.0 and the built-in enzyme kinetics module were used to determine Michaelis-Menten kinetic parameters, k cat and K m , for both ATP and ENSA. All kinases assays were conducted thrice in triplicate (n = 9) and IC 50 values are reported as the mean ± 1 S.D.
Immunoprecipitation Kinase Assay
HEK293T cells were transfected with 10 g of plasmid (Flag-tagged hGWL FL or GFP; pcDNA3-EGFP, Addgene, Cambridge MA, USA) using CaCl 2 . 48 hours later 100 ng/ml nocodazole was added to the media and incubated for a further 16-18 h. Cells were collected and washed in PBS-A followed by lysis on ice for 20 min in 1mL IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% v/v glycerol, 0.5% v/v NP-40, 1 mM EDTA supplemented with protease and phosphatase inhibitors (Complete and PhosStop; Roche Diagnostics)). Samples were then sonicated and clarified by centrifugation at 13,000 rpm for 30 min at 4°C. To capture Flag-tagged S 4 hGWL FL , 100 l of lysate was diluted 5-fold with IP buffer and combined with 3 l anti-Flag M2 magnetic Dynabeads [Sigma-Aldrich] overnight at 4 °C. After sequential washes with IP buffer, 1:1 mix of IP and kinase assay buffers and a final wash in kinase assay buffer, the beads were then used in the kinase assay. The reaction was stopped by adding SDS loading buffer and analysed by western blot: p-ENSA and GWL levels were detected using the anti-phospho(Ser67)-ENSA and anti-MASTL(GWL, Prestige) antibodies. Activity was measured as the p-ENSA/GWL ratio and % kinase activity was normalised to the DMSO control. All kinases assays were repeated thrice per assay condition and each point on the concentration-dependent response curves represents the mean ± 1 S.D.
PKA, ROCK1 and CDK2 kinase assays PKA and ROCK1 assays (Promega) were carried out according to the manufacturer's protocols and CDK2 assays were carried out with Histone H1 as substrate (1 g per 20 l reaction) according to our Kinase-Glo Max assay. CDK2 was expressed and purified from E. coli as previously described (10) .
Inhibitor Screens with hGWL-KinDom
Two small-molecule compound libraries, enriched with pharmacophores known to interact with the ATPbinding site of protein kinases, were kindly provided by GlaxoSmithKline and Roche. We used this pooled library (582 compounds, 10 M screening concentrations) in a Kinase-Glo Max luminescence kinase assay (11, 12) as part of a two-point screen against hGWL-KinDom kinase activity, using ATP at fixed concentrations of 15 M and 45 M; ~1-and 3-fold the Km value for ATP respectively. With STU as positive control at a concentration of 200 M, Z-factor values for screening plates ranged from 0.41 to 0.69 (Supplementary Figure  4A,B) . A threshold value of 3 was used to identify 34 hits, all with inhibitory activity greater than 30% (hit rate = 5.8%; Supplementary Figure 4A ). Molecular Docking -AutoDock AT13148 and GKI-1/2 were docked into the ATP-binding site of the hGWL-KinDom crystal structure (where the disordered C-helix was homology-modelled) using AutoDock 4.2.6. PDB format files for the ligand and kinase domain were pre-processed using AutoDock Tools 1.5.6 as described in Mohamed, et al. (13) . (Figure 4 and Supplementary Figure 6A S 6 Figure S2 . Detection of phosphorylation sites in hGWL-KinDom produced in E. coli (A) A band corresponding to hGWL-KinDom was subjected to in-gel digestion with trypsin before mass spectrometric (MS) analysis (Proteomics Facility, University of Bristol). All the raw spectra from MS were analyzed using MASCOT and MaxQuant as search engines, and searched against an in-house database containing either the hGWL-KinDom sequence or the UNIPROT_ALL.fasta database. The search parameters are as follows: Carbamidomethyl (C) as Fixed modification; Oxidation (M), Deamidated (NQ), Phospho (ST), Phospho (Y) as Variable modification, taxonomy selected to Homo sapiens, Peptide mass tolerance of 10 ppm, fragment mass tolerance of 0.7 Da, allowing missed cleavage site of 1. Peptide identification was done using parameters such as peptide ion scores >31, which indicate identity or extensive homology (p < 0.05). Phospho-site Ser878 was identified using MASCOT and all others were identified using both MASCOT and MaxQuant. Immunoprecipitated hGWL FL was treated with increasing concentrations of GKI-2 and kinase activity was measured using the immunoprecipitation kinase assay. (D) % kinase activity was normalised to the DMSO control and plotted against GKI-2 concentration using Prism 6.0. 
